Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Innovative Pharmaceutical Biotech ( (HK:0399) ) just unveiled an update.
Starcoin Group Limited has issued a clarification regarding an online media article that falsely claimed the company had entered into a merger and acquisition agreement with Tianxingjian Health Industry Group. The company firmly denies any such agreement or affiliation with Tianxingjian and reserves the right to pursue legal action to protect its interests and those of its shareholders. Shareholders and potential investors are advised to rely only on official company announcements and exercise caution when dealing with the company’s securities.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, is incorporated in the Cayman Islands and continued in Bermuda with limited liability. The company operates in the pharmaceutical and biotech industry, focusing on innovative solutions and products.
Average Trading Volume: 22,169,248
Technical Sentiment Signal: Buy
Current Market Cap: HK$642.8M
For an in-depth examination of 0399 stock, go to TipRanks’ Overview page.